INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 August 2011
Total net assets |
£92.3m |
NAV per share |
164.9p |
Share price |
143.0p |
Total value of unquoted investments |
£23.3m |
Total number of portfolio companies |
66 |
Cash |
(10)% NAV |
Cash committed and reserved to unquoted investments |
(10)% NAV |
Portfolio companies with < 1 year of cash |
13% NAV |
Top Ten Holdings
Company Name |
% NAV |
Amgen |
5.9 |
Cadent |
5.4 |
Teva |
5.3 |
Gilead Sciences |
5.1 |
Insulet |
4.3 |
Pharmasset |
4.3 |
Celgene |
4.1 |
Shire |
4.0 |
Micromet |
3.3 |
Axis-Shield |
3.3 |
|
----------- |
Total |
45.0 |
Geographical Allocation |
% |
United States |
85 |
Europe |
18 |
Israel |
5 |
Australia |
2 |
Cash |
(10) |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% |
Quoted |
85 |
Unquoted |
25 |
Cash |
(10) |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
14 SEPTEMBER 2011